Pro-Dex, Inc. (NASDAQ:PDEX) Director Sells $50,000.00 in Stock

Pro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot sold 1,000 shares of the business’s stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $50.00, for a total transaction of $50,000.00. Following the sale, the director now directly owns 299,695 shares in the company, valued at approximately $14,984,750. The trade was a 0.33 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Pro-Dex Price Performance

Shares of NASDAQ PDEX traded down $0.13 during midday trading on Friday, reaching $48.92. 14,151 shares of the company were exchanged, compared to its average volume of 21,678. The stock’s 50-day moving average price is $39.74 and its 200-day moving average price is $38.81. The stock has a market cap of $159.53 million, a P/E ratio of 24.34 and a beta of 0.68. Pro-Dex, Inc. has a one year low of $16.84 and a one year high of $59.60. The company has a quick ratio of 1.44, a current ratio of 2.58 and a debt-to-equity ratio of 0.33.

Pro-Dex (NASDAQ:PDEX) last posted its earnings results on Thursday, January 30th. The medical instruments supplier reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.23. Pro-Dex had a net margin of 11.06% and a return on equity of 21.68%. On average, sell-side analysts anticipate that Pro-Dex, Inc. will post 2 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, StockNews.com cut shares of Pro-Dex from a “buy” rating to a “hold” rating in a research note on Wednesday, March 12th.

Hedge Funds Weigh In On Pro-Dex

A number of hedge funds have recently modified their holdings of PDEX. EAM Investors LLC acquired a new position in shares of Pro-Dex during the fourth quarter worth $1,047,000. O Shaughnessy Asset Management LLC acquired a new position in shares of Pro-Dex during the fourth quarter worth $995,000. 683 Capital Management LLC acquired a new position in shares of Pro-Dex during the fourth quarter worth $739,000. Ritholtz Wealth Management acquired a new position in shares of Pro-Dex during the fourth quarter worth $572,000. Finally, American Century Companies Inc. acquired a new position in shares of Pro-Dex during the fourth quarter worth $558,000. Institutional investors and hedge funds own 15.28% of the company’s stock.

About Pro-Dex

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.